Outcomes by Sex Following Treatment Initiation With Atazanavir Plus Ritonavir or Efavirenz With Abacavir/Lamivudine or Tenofovir/Emtricitabine
Author(s) -
Kimberly Y. Smith,
Camlin Tierney,
Katie R. Mollan,
Charles S. Venuto,
Chakra Budhathoki,
Qing Ma,
Gene D. Morse,
Paul E. Sax,
David Katzenstein,
Catherine Godfrey,
Margaret A. Fischl,
Eric S. Daar,
Ann C. Collier
Publication year - 2014
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/he3y-dk56
Subject(s) - efavirenz , abacavir , emtricitabine , atazanavir , lamivudine , ritonavir , tenofovir , medicine , virology , pharmacology , human immunodeficiency virus (hiv) , antiretroviral therapy , viral load , hepatitis b virus , virus
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom